Company & Sponsor Intelligence

Sunnybrook Health Sciences Centre

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting5

Completed3

Countries1

Therapeutic footprint

alzheimersbipolar_disorderdementia_otherdepressiontraumatic_brain_injury

Indexed studies

NCT06773416CPAP Randomized Controlled Trial
dementia_other · CanadaNA

NCT02085265Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
alzheimers · CanadaPHASE2

NCT04516057Nabilone for Agitation Blinded Intervention Trial
alzheimers · CanadaPHASE3

NCT07694258Assessment of Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Disorders of Consciousness
traumatic_brain_injury · CanadaNA

NCT07477431Levetiracetam for Persons at Risk for Alzheimer's Disease
alzheimers · CanadaPHASE2

NCT03670615Using Exercise and Electrical Brain Stimulation to Improve Memory in Dementia
alzheimers · CanadaNA

NCT01928043Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations
bipolar_disorder · CanadaPHASE2

NCT05374213Virtual Mindfulness Intervention RCT
depression · CanadaNA

NCT02593643Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
depression · CanadaEARLY_PHASE1

NCT07279740Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
alzheimers · CanadaPHASE2

NCT06178731Virtual Reality Reward Training and Transcranial Magnetic Stimulation for Depression
depression · CanadaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →